FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Friday

 

New drug gives hope for those with progressive MS: VIDEO























Jerrie Gullick, who has multiple sclerosis.  CBS NEWS

As many as 400,000 Americans are believed to suffer from multiple sclerosis -- a debilitating disease of the central nervous system. A new drug may provide relief from the most devastating form of MS.

Six years ago, at age 45, Jerrie Gullick suddenly developed leg and back pain, numbness, and severe fatigue. She was barely able to walk, and working at a demanding job became impossible.

“I had to quit about 7-8 months after I got my diagnosis,” she said. “The fatigue was overwhelming.” 

The diagnosis was multiple sclerosis. 

Many MS patients can manage their disease through the use of several helpful medications, but Gullick is one of the 10 to 15 percent who have progressive MS, which has no approved treatment and continuously gets worse.

Three years ago, she joined a trial of a new intravenous drug called Ocrelizumab. 

It targets an immune system cell which, in MS, is felt to mistakenly attack the nervous system. 

In the more serious progressive form that Gullick has, the drug slowed down the rate of disability by about 25 percent.

Neurologist Dr. Fred Lublin of Mount Sinai Hospital in New York City worked on the trial.

“It’s a very big deal. You have to start with success and this is the start. And so this is for us the start of treating progressive MS, the treating progressive MS era,” he said. 

Gullick said this drug is giving her new hope.

“This is what I’m gonna have for the next 20 years and that’s okay, whereas before I was thinking in 5 years I’m going to be bedridden,” said Gullick.

Gullick can see the silhouette of at least an acceptable future. 

This drug works by suppressing the immune system, and researchers are still looking at it closely for any serious side effects. The FDA is expected to make a decision about possible approval by the end of March.

Story Source: The above story is based on materials provided by CBSNEWS
Note: Materials may be edited for content and length

Labels: ,



Go to Newer News Go to Older News